However, in 3xTg‐AD mice, PAK1 KO or reduced PAK activity worsened synaptic and cognitive impairments and elevated phosphorylated tau (p‐tau) levels in aged animals, despite having no effect on Aβ pathology.20, 21. The gene discussed is MAPT; the disease is Cognitive impairment.